Clinical observation of a new anti anxiety agent derived from phenothiazine
Simoes Vieira, J.C.
Hospital (Rio de Janeiro) 78(4): 197-203
1970
ISSN/ISBN: 0018-5469 Accession: 026267426
Full Text Article emailed within 1 workday: $29.90
Related References
Clare, N.T. 1947: A photosensitized keratitis in young cattle following the use of phenothiazine as an anthelmintic I A clinical description with a note on its widespread occurrence in New Zealand II The metabolism of phenothiazine in ruminants III Identification of the photosensitizing agent Australian Vet Jour: 336-348Boutillier; Raybaud; Corsetti; Ducamin, J.P. 1963: 1st Clinical Results of a new Anti-Anxiety Agent, Ro5-2807 Annales Medico-Psychologiques 121: 397-404
Ishigooka, J. 1999: Clinical presentation of anti-anxiety and tranquilizing agent dependence Nihon Shinkei Seishin Yakurigaku Zasshi 19(4): 219-222
Abuzzahab, F.S.; Kulkarni, A.S. 1974: A pilot investigation of clinical effects of PM-33, a new anti-anxiety agent Current Therapeutic Research 16(11): 1181-1186
Gaztanaga, P.; Abrams, R.; Simeon, J.; Jones, T.; Fink, M. 1972: Clinical evaluation of GP-41299). An anti-anxiety agent of the doxepine type Arzneimittel-Forschung 22(11): 1903-1905
Itil, T.; Gannon, P.; Cora, R.; Polvan, N.; Akpinar, S.; Elveris, F.; Eskazan, E. 1972: SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials) Behavioral Neuropsychiatry 4(4-5): 15-24
Carlson, E.J.; Rupniak, N.M. 2003: Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent for treatment of depression or anxiety Official Gazette of the United States Patent and Trademark Office Patents 1276(3)
Itil, T.; Gannon, P.; Cora, R.; Polvan, N.; Akpinar, S.; Elveris, F.; Eskazan, E. 1972: Sch 12 041 chloro 1 3 dihydro 5 phenyl 1 2 2 2 trifluoroethyl 2h 1 4 benzodiazepin 2 one a new anti anxiety agent quantitative pharmaco electro encephalography and clinical trials Behav Neuropsychiatry 4(4-5): 15-24
Uzan, A.; Gueremy, C.; Le Fur, G. 1976: Biotransformation of 10-(3-quinuclidinylmethyl)phenothiazine (LM 209), a new anti-allergy agent and the distribution and excretion of its metabolites Xenobiotica; the Fate of Foreign Compounds in Biological Systems 6(11): 649-665
Vieira, J.C. 1970: Clinical observation of a new anxiolytic phenothiazine derivative Hospital (Rio de Janeiro) 78(4): 1147-1153
Halpern, B.N.; Hamburger, J. 1948: A new synthetic anti-histamine substance derived from phenothiazine; phenergan, 3,277 R.P Canadian Medical Association Journal 59(4): 322-326
Halpern, B.N.; Bessis, M. 1950: Anti-spherocytic action of certain synthetic substances derived from phenothiazine Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 144(11-12): 759-760
Markosian, R.A.; Pozin, E.I.; Popov, E.G.; Rozenshtraukh, L.V. 1983: Antiaggregating action on thrombocytes of a new anti-arrhythmia agent of the phenothiazine series--diethylamine ethmozine analog Biulleten' Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn SSSR 6(2): 64-66
Uzan, A.; Le-Fur, G. 1976: Inhibition of guinea pig lung cyclic amp phospho di esterase by a new anti allergic agent lm 209 10 3 quinuclidinylmethyl phenothiazine Archives Internationales de Pharmacodynamie et de Therapie 219(1): 160-166
Wiedling, S. 1957: Pharmacological and toxicological studies on -diethylaminoethyl phenothiazine-10-carboxylate hydrochloride , a new spasmolytic and anti-Parkinsonism agent Acta Pharmacol Et Toxicol 13(1): 59-79